Highlights Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-07-17 am EDT			5-day change	1st Jan Change
0.043 ^AUD	0.00%		-6.52%	-41.10%

Jul. 09	Lumos Diagnostics Expands Distribution Deal with Henry Schein for Respiratory Infection Test	MT
Jul. 04	Lumos Diagnostics Expands Distribution Deal with Regional Health Care Group for Respiratory Infection Test	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lumos Diagnostics Expands Distribution Deal with Regional Health Care Group for Respiratory Infection Test	Jul. 03	MT
Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3%	Jun. 19	MT
Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8%	Jun. 03	MT
Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	May. 05	MT
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	Apr. 08	MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%	Feb. 11	MT
Lumos Diagnostics Signs Development and IP Agreements with Hologic; Shares Up 24%	Jan. 10	MT
Lumos Signs Major Development and IP Agreements with Hologic, Inc	Jan. 10	CI
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader	23-08-16	MT
Lumos Diagnostics Expands FebriDx Market to Netherlands	23-08-16	MT
Lumos Diagnostics Announces Core Camera Reader Patent Granted in Europe and Japan	23-08-15	CI
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022	23-08-10	MT
Lumos Diagnostics Signs Partnership with Henry Schein Medical for FebriDx Distribution; Shares Jump 8%	23-07-17	MT
Lumos Diagnostics Secures US FDA Clearance for Bacterial Respiratory Infection Test	23-07-03	MT
Lumos Diagnostics Secures AU$9 Million in Funding from New Agreements With US Healthcare Company	23-03-16	MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI
Lumos Diagnostics Wins Two Service Agreements from Health Company Hologic	22-11-23	MT
Lumos Diagnostics Secures Two Service Agreements with Hologic	22-11-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Highlights

Filters